Tag: Hyperkalemia

Good Doctors...Better People

There's A New Binder On the Block: FDA Approves Patiromer

October 22, 2015

BETHESDA, MD — The US Food and Drug Administration (FDA) has approved a new oral option for reversing hyperkalemia, patiromer. Patiromer is an oral suspension (Veltassa, Relypsa) that has just come out of the phase-2 AMETHYST-DN study, which  showed that daily administration of the potassium-binding agent safely controlled hyperkalemia over a 1 year in patients…
Read more

Has Kayexlate Finally Pooped Out??

February 26, 2015

So I’ve talk to multiple students and residents and tried to convey the idea that we shouldn’t be so gungho to use kayexlate acutely for hyperkalemia in the hospital (same with the outpatient setting). There is a plaucity of evidence that this resin does very much outside of . Of course it is easier to…
Read more

©  2024 Tulane Nephrology Fellowship. Built using WordPress and the Mesmerize Theme